{"nodes": [{"id": "secondary processes"}, {"id": "federal poverty level"}, {"id": "mystical-type experiences"}, {"id": "5-ht2a receptors"}, {"id": "psychotic-like states"}, {"id": "molecular mechanism"}, {"id": "LSD"}, {"id": "primary process"}, {"id": "metachronous recurrent tumors"}, {"id": "mystical experiences"}, {"id": "primary process thinking"}, {"id": "european association"}, {"id": "psychedelic drugs"}, {"id": "pharmacological model"}, {"id": "cannabinoid receptors"}, {"id": "acute administration"}, {"id": "primary index"}, {"id": "adjacent oligodendrocytes"}, {"id": "postnatal depression"}, {"id": "5-ht2a receptor"}, {"id": "psychedelic therapy"}, {"id": "mystical experience"}, {"id": "visionary experiences"}, {"id": "prefrontal cortex"}, {"id": "psychotic-like effects"}, {"id": "selective cb2 receptor"}, {"id": "electronic material"}, {"id": "blissful state"}, {"id": "primary index lesion"}, {"id": "psychoactive component"}, {"id": "neurobiological mechanisms"}], "links": [{"source": "5-ht2a receptor", "target": "prefrontal cortex", "value": 10}, {"source": "primary index", "target": "primary process", "value": 10}, {"source": "mystical experiences", "target": "mystical-type experiences", "value": 10}, {"source": "primary index", "target": "federal poverty level", "value": 10}, {"source": "blissful state", "target": "primary index", "value": 10}, {"source": "psychotic-like effects", "target": "psychoactive component", "value": 10}, {"source": "blissful state", "target": "mystical experiences", "value": 10}, {"source": "LSD", "target": "mystical experiences", "value": 10}, {"source": "blissful state", "target": "psychedelic therapy", "value": 10}, {"source": "psychotic-like effects", "target": "pharmacological model", "value": 10}, {"source": "psychotic-like effects", "target": "psychotic-like states", "value": 10}, {"source": "LSD", "target": "primary index", "value": 10}, {"source": "5-ht2a receptor", "target": "selective cb2 receptor", "value": 10}, {"source": "primary index", "target": "european association", "value": 10}, {"source": "mystical experiences", "target": "mystical experience", "value": 10}, {"source": "mystical experiences", "target": "visionary experiences", "value": 10}, {"source": "5-ht2a receptor", "target": "cannabinoid receptors", "value": 10}, {"source": "primary process", "target": "primary index", "value": 10}, {"source": "blissful state", "target": "primary process", "value": 10}, {"source": "5-ht2a receptor", "target": "molecular mechanism", "value": 10}, {"source": "psychotic-like effects", "target": "neurobiological mechanisms", "value": 10}, {"source": "blissful state", "target": "electronic material", "value": 10}, {"source": "primary index", "target": "metachronous recurrent tumors", "value": 10}, {"source": "LSD", "target": "blissful state", "value": 10}, {"source": "psychotic-like effects", "target": "acute administration", "value": 10}, {"source": "LSD", "target": "psychotic-like effects", "value": 10}, {"source": "primary process", "target": "postnatal depression", "value": 10}, {"source": "5-ht2a receptor", "target": "5-ht2a receptor", "value": 10}, {"source": "primary process", "target": "adjacent oligodendrocytes", "value": 10}, {"source": "primary process", "target": "primary process thinking", "value": 10}, {"source": "mystical experiences", "target": "psychedelic drugs", "value": 10}, {"source": "5-ht2a receptor", "target": "5-ht2a receptors", "value": 10}, {"source": "LSD", "target": "primary process", "value": 10}, {"source": "primary index", "target": "primary index lesion", "value": 10}, {"source": "primary process", "target": "secondary processes", "value": 10}, {"source": "mystical experiences", "target": "psychedelic therapy", "value": 10}, {"source": "LSD", "target": "5-ht2a receptor", "value": 10}]}